EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes

Qian Jia, Qincheng Che, Xiaoyu Zhang, Jie Chen, Chunfeng Ren, Yunpeng Wu, Weiqiang Liang, Xiaojie Zhang, Yanshan Li, Zunzhong Li, Zhenchun Zhang, Qiang Shu

Biochemical Pharmacology · 2024-02 · 220 · 115994

DOI: 10.1016/j.bcp.2023.115994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024-02. Verfasst von Qian Jia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Department of Rheumatology and Immunology,…. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid, Synoviocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of Galectin-9 (Gal-9) in the pathogenesis of rheumatoid arthritis (RA) remains unclear. This study aimed to investigate the mechanism of action and therapeutic potential of Gal-9 in RA. We detected Gal-9 expression in clinical samples, explored the mechanism of function of Gal-9 by knockdown and overexpression in fibroblast-like synoviocytes (FLSs), and further verified it in collagen-induced arthritis (CIA) model. We found that the levels of Gal-9 were considerably elevated in RA synovium than in osteoarthritis (OA) patients. A substantial decrease of Gal-9 was demonstrated after tumor necrosis factor (TNF-α) inhibitor treatment in the plasma of patients with RA. Additionally, transcriptome sequencing revealed that Gal-9 was involved in the regulation of the TNF-α pathway. Gal-9 was considerably upregulated after TNF-α stimulation in FLSs, and knockdown of Gal-9 substantially inhibited TNF-α activated proliferation, migration and inflammatory response. According to cell transcriptome sequencing results, we further confirmed that Gal-9 could achieve these effects by interacting with MAFB and affecting PI3K/AKT/mTOR pathway. Finally, we knocked down Gal-9 on the CIA model and found that it could alleviate the progression of arthritis. In conclusion, our study revealed that the knockdown of Gal-9 could inhibited TNF-α induced activation in RA through MAFB, PI3K/AKT/mTOR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalArthritis, RheumatoidSynoviocytesAnimalsHumansCell ProliferationCells, CulturedFibroblastsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaGalectins

Stichwörter der Autor:innen

Collagen-induced arthritisFibroblast-like synoviocytesGalectin-9MAFBRheumatoid arthritisTNF-α

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesTumor Necrosis Factor-alphaLGALS9 protein, humanGalectins

Autor:innen und Institutionen

  • Department of Rheumatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Department of Rheumatology and Immunology, Linyi People's Hospital, Linyi, China; Department of Rheumatology, Li…
  • Department of Rheumatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Department of Rheumatology, Qilu Hospital, Shandong Provincial Clinical Research Center for Immune Diseases and…
  • Department of Rheumatology and Immunology, Jining NO.1 People's Hospital, Jining, China.
  • Department of Orthopedics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Bone and Joint Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
  • Department of Rheumatology and Immunology, Linyi People's Hospital, Linyi, China; Department of Rheumatology, Linyi People's Hospital, Shandong Provincial Clinical Research Center for Immune Diseases and Gout, Linyi, Ch…

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Jia, Q., Che, Q., Zhang, X., Chen, J., Ren, C., Wu, Y., Liang, W., Zhang, X., Li, Y., Li, Z., Zhang, Z., & Shu, Q. (2024). Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes. Biochemical Pharmacology, 220, 115994. https://doi.org/10.1016/j.bcp.2023.115994

Vancouver

Jia Q, Che Q, Zhang X, Chen J, Ren C, Wu Y, et al. Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes. Biochemical Pharmacology. 2024;220:115994. doi:10.1016/j.bcp.2023.115994

BibTeX
@article{Jia2024,
  author = {Jia, Qian and Che, Qincheng and Zhang, Xiaoyu and Chen, Jie and Ren, Chunfeng and Wu, Yunpeng and Liang, Weiqiang and Zhang, Xiaojie and Li, Yanshan and Li, Zunzhong and Zhang, Zhenchun and Shu, Qiang},
  title = {Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes},
  journal = {Biochemical Pharmacology},
  year = {2024},
  volume = {220},
  pages = {115994},
  doi = {10.1016/j.bcp.2023.115994}
}
Kostenlos starten →